Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donald J. Rogier is active.

Publication


Featured researches published by Donald J. Rogier.


Bioorganic & Medicinal Chemistry Letters | 1996

Conformationally restricted 1,5-diarylpyrazoles are selective COX-2 inhibitors

Stephen R. Bertenshaw; John J. Talley; Donald J. Rogier; Matthew J. Graneto; Carol M. Koboldt; Yan Zhang

Abstract Benzothiopyranopyrazoles and benzopyranopyrazoles containing either a sulfone or sulfonamide moiety were synthesized and tested for COX-1 and COX-2 inhibition. This new class of COX-2 selective inhibitors possess antiinflammatory activity in vivo.


Bioorganic & Medicinal Chemistry Letters | 1999

Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors

Jeffery S. Carter; Donald J. Rogier; Matthew J. Graneto; Karen Seibert; Carol M. Koboldt; Yan Zhang; John J. Talley

A series of novel sulfone substituted 4,5-diarylthiazoles have been synthesized and evaluated for their inhibition of the two isoforms of human cyclooxygenase (COX-1 and COX-2). This series displays exceptionally selective COX-2 inhibition.


Bioorganic & Medicinal Chemistry Letters | 1995

3,4-diarylthiophenes are selective COX-2 inhibitors

Stephen R. Bertenshaw; John J. Talley; Donald J. Rogier; Matthew J. Graneto; Roland S. Rogers; Steven W. Kramer; Thomas D. Penning; Carol M. Koboldt; Amy W. Veenhuizen; Yan Zhang; William E. Perkins

Abstract A group of 3,4-diarylthiophenes containing either a sulfone or sulfonamide moiety were synthesized and tested for COX-1 and COX-2 inhibition. They are selective inhibitors of COX-2 and possess antiinflammatory activity in vivo .


Archive | 1993

Substituted pyrazolyl benzenesulfonamides

John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter


Archive | 1994

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter; Stephen H Docter; Stella S. Yu


Archive | 1998

Prodrugs of benzenesulfonamide-containing COX-2 inhibitors

John J. Talley; James W. Malecha; Stephen R. Bertenshaw; Matthew J. Graneto; Jeffery S. Carter; Jinglin Li; Srinivasan Nagarajan; David L. Brown; Donald J. Rogier; Thomas D. Penning; Ish K. Khanna; Xiangdong Xu; Richard M. Weier


Archive | 1998

Substituted benzopyran derivatives for the treatment of inflammation

Jeffery S. Carter; Mark G. Obukowicz; Balekudru Devadas; John J. Talley; David L. Brown; Matthew J. Graneto; Stephen R. Bertenshaw; Donald J. Rogier; Srinivasan Nagarajan; Cathleen E Hanau; Susan J. Hartmann; Cindy L Ludwig; Suzanne Metz


Archive | 1994

1,3,5 trisubstituted pyrazole compounds for treatment of inflammation

John J. Talley; Donald J. Rogier; Thomas D. Penning; Stella S. Yu


Archive | 1999

Substituted benzopyran analogs for the treatment of inflammation

Jeffery S. Carter; Mark G. Obukowicz; Balekudru Devadas; John J. Talley; David L. Brown; Matthew J. Graneto; Stephen R. Bertenshaw; Donald J. Rogier; Srinivasan Nagarajan; Cathleen E Hanau; Susan J. Hartmann; Cindy L Ludwig; Suzanne Metz; Donald E. Korte


Archive | 1995

Substituted thiazoles for the treatment of inflammation

John J. Talley; Jeffery S. Carter; Paul W. Collins; Steven W. Kramer; Thomas D. Penning; Donald J. Rogier; Roland S. Rogers

Collaboration


Dive into the Donald J. Rogier's collaboration.

Researchain Logo
Decentralizing Knowledge